Skip to main content
. 2024 Nov 12;19:423. doi: 10.1186/s13023-024-03369-6

Table 1.

Comparison of phenotypes between R288X and non-R288X patients

Phenotypes Group Total
R288X Non-R288X
Number of patients 93 32 125
Psychomotor delay 93/93(100%) 31/32(96.9%) 124/125(99.2%)
Microcephaly 53/93(57%) 18/32(56.3%) 71/125(56.8%)
Epilepsy 76/93(81.7%) 22/32(68.8%) 98/125(78.4%)
Dystonia/Movement disorder 55/93(59.1%) 25/32(78.1%) 80/125(64%)
Sit or walk independently 14/93(15.1%) 2/32(6.3%) 16/125(12.8%)
Developmental stagnation/failure to thrive 93/93(100%)A 7/32(21.9%)B 100/125(80%)
Development delay 91/93(97.8%)C 27/32(84.4%)D 118/125(94.4%)
Hearing impairment 28/93(30.1%) 13/32(40.6%) 41/125(32.8%)
Vision impairment 26/93(28.0%) 12/32(37.5%) 38/125(30.4%)
Abnormal pigmentation 29/93(31.2%) 14/32(43.8%) 43/125(34.4%)
Irritability 74/93(79.6%)E 16/32(50%)F 90/125(72%)
Feeding difficulties 36/93(38.7%) 16/32(50%) 52/125(41.6%)
Gastrostomy feeding tube 27/93(29.0%)G 3/32(9.4%)H 30/125(24%)
Facial dysmorphic features 0/93(0%)I 7/32(21.9%)J 7/125(5.6%)
Scoliosis 14/93(15.1%) 5/32(15.6%) 19/125(15.2%)
Abnormal electroencephalographic 43/93(46.2%) 9/32(28.1%) 52/125(41.6%)

A versus B: P = p = 0.000 (Pearson’s Chi-squared test); C versus D: P = 0.016 (Yates’ continuity correction of the Chi-squared test); E versus F: P = 0.001 (Pearson’s Chi-squared test); GvsH: P = 0.025 (Pearson’s Chi-squared test); I versus J: P = 0.000 (Yates’ continuity correction of the Chi-squared test)